High dose Ursodeoxycholic acid (UDCA), 25-30mg/kg/day
May improve liver chemistries but does not slow disease progression and may actually hasten development of portal hypertension
Periodic dilation of strictures via ERCP or percutaneous route
Liver Transplant should be offered to those with advanced liver disease or repeated bouts of<unk>  (disease can recur after transplantation)
May improve liver chemistries but does not slow disease progression and may actually hasten development of portal hypertension
Primary sclerosing cholangitis
Amebiasis
Ischemic hepatitis
Autoimmune hepatitis
Choledocholithiasis
Viral hepatitis
Non-alcoholic steatohepatitis
Acute alcoholic hepatitis